Given the inhibitory effects of STAT3 signaling on NK cells, we found that CAFs in PDA were a major contributor to the inhibition of NK cell function due to IL‐6 secretion, resulting in the loss of innate immune antitumor effects. The gene discussed is IL6; the disease is Patent ductus arteriosus.